Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis
<jats:sec><jats:title>Background</jats:title><jats:p>Biomarkers of disease progression and treatment response are urgently needed for patients with lymphangioleiomyomatosis (LAM). Activity-based nanosensors, an emerging biosensor class, detect dysregulated proteases <jats:...
Main Authors: | Kirkpatrick, Jesse D (Author), Soleimany, Ava P (Author), Dudani, Jaideep S (Author), Liu, Heng-Jia (Author), Lam, Hilaire C (Author), Priolo, Carmen (Author), Henske, Elizabeth P (Author), Bhatia, Sangeeta N (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society (ERS),
2022-05-27T18:36:46Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Harnessing protease activity to improve cancer care
by: Dudani, Jaideep S., et al.
Published: (2020) -
Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer
by: Souheil El-Chemaly, et al.
Published: (2014-03-01) -
MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
by: Anil J Trindade, et al.
Published: (2013-01-01) -
Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling
by: Schuerle, Simone, et al.
Published: (2017) -
Protease activity sensors noninvasively classify bacterial infections and antibiotic responses
by: Buss, Colin G., et al.
Published: (2019)